here you can read it clinton said oral sex is not

New Post Public Reply Private Reply Replies (0) Message Board
john1234 Bhawks #24497
here you can read it clinton said oral sex is not sex


Clinton's three lies, according to Starr

By Brooks Jackson/CNN

(Editor's Note: This story contains explicit language.)

WASHINGTON (September 21) -- Independent Counsel Ken Starr says President Bill Clinton's videotaped testimony contains three lies -- three instances of perjury to the federal grand jury.

Lie number one, according to Starr: Oral sex is not sex.

"Is oral sex performed on you within that definition as you understood it?" Clinton was asked during his August 17 testimony, viewed by the public for the first time Monday.

"As I understood it, it was not, no," the president answered.

Lawyers in the Paula Jones sexual harrassment case defined "sexual relations" as engaging in or causing "contact with the genitalia, anus, groin, breast, inner thigh or buttocks of any person..."

But the president said,"If the deponent is the person who has oral sex performed on him, then the contact is with -- not with anything on that list -- but with the lips of another person."

Starr didn't buy that explanation.

"That testimony is not credible. At the Jones deposition, the president could not have believed he was telling the truth, the whole truth and nothing but the truth," the independent counsel wrote to Congress.

The president's lawyers said in rebuttal that oral sex "plainly" falls outside the Jones definition.

Lie number two, alleged by Starr

Lie number two, according to Starr: It was a one-way relationship.

The president seemed to deny kissing Lewinsky's breasts or touching her breast or groin.

"So you didn't do any of those three things with Monica Lewinsky?" Clinton was asked.

"You are free to infer that my testimony is that I did not have sexual relations, as I understood this term to be defined," Clinton answered.

"Including, touching her breast, kissing her breast, or touching her genitalia?" prosecutors asked again.

"That's correct," Clinton said.

But Lewinsky testified that the president touched her sexually nine times.

"Out of all of the times you had intimate contact, were there times when the president would touch you either on the breasts or in the genital area directly to the skin or was it always though clothing?" prosecutors asked Lewinsky during her sworn grand jury testimony.

"Directly to the skin. Both," Lewinsky answered.

Starr believes the president lied again.

"On all nine of those occasions, the president fondled and kissed her bare breasts. He touched her genitals ... bringing her to orgasm on two occasions," Starr wrote.

The independent counsel claims Lewinsky's version is backed up by testimony from friends and family members who say she told them about the encounters at the time and by a letter Lewinsky drafted to the president referring to sexual touching.

"Either Monica Lewinsky lied to the grand jury, or President Clinton lied ... under any rational view of the evidence, the president lied," Starr concluded.

The president's lawyers question whether evidence backs up Lewinsky, and say no one can be convicted of perjury just because their testimony conflicts with that of one other witness.

Lie number three

Lie number three, Starr says, is implicit, not explicit: The question of when the affair began.

"When I was alone with Ms. Lewinsky on certain occasions in early 1996 and once in early 1997, I engaged in conduct that was wrong," Clinton admitted in a prepared statement he read during his grand jury testimony.

But Lewinsky testified she first administered oral sex November 15, 1995 and again, two days later. Both encounters happened during the government shutdown, according to Lewinsky.

She said the president tugged at her intern credentials saying that could be "a problem." She said only by their third encounter, on the last day of 1995, was she a full member of the White House staff.

Starr claims the president lied about the dates to cover up the fact that the affair began when Lewinsky was a 22-year-old intern.

Clinton's lawyers call that allegation "frivolous" and said the discrepancy in dates is "an utterly immaterial statement."

Overall Clinton's legal team says there is no evidence that the president knowingly gave false testimony; the questions were ambiguous, and even misleading answers can't be perjury if literally true.

When Clinton testified, he knew Lewinsky was talking to Starr's prosecutors, and he knew his DNA could match a stain on her dress.

Faced with those facts, the president could have invoked the Fifth Amendment, refusing to incriminate himself before the grand jury.

Instead, according to Starr, he continued to lie.

source
http://www.cnn.com/ALLPOLITICS/stories/1998/0...s.jackson/

Scroll down for more posts ▼

Top 10 Most Recent News Articles

WEPSEA 2026 Propels Southeast Asia's Packaging Leap

Updated Category News Views 1

Revolution in Packaging: Southeast Asia Steps Up Get ready for a wake-up call in the world of packaging, folks; the Southeast Asian market is taking a sharp turn toward sustainability and technological advancement, as highlighted by WEPSEA 2026's recent wrap-up in Shanghai. Far from a mere exhibition, this gathering served as the crucible for change, where old-school...

Continue Reading
DUVA ONE Sleep Earbuds: Real-Time Innovation Debuts

Updated Category News Views 3

While You Dream, DUVA ONE Works Here's the scoop: DUVA just took sleep tech to another level with their DUVA ONE earbuds launched at Berlin's IFA 2026. These aren't just any earbuds; they're engineered to actually do something while you're sleeping. DUVA ONE senses what’s happening during your snooze session and adjusts right on the fly. The Night Patrol: In-Ear and...

Continue Reading
Clover's RSV Combo Vaccine Shows Promise in Trials

Updated Category News Views 3

In the biotech world, there's always a race. Clover Biopharmaceuticals is making strides with their RSV+hMPV vaccine candidate, especially for the elderly. Imagine those big leaps in development—all boosted by recent results from a Phase 2 trial down under in Australia. Key Findings of the Trial Immunogenicity Insights They're not messing around with these findings. The...

Continue Reading
Changhong's IFA 2026 Showcase: AI, Culture & Localization

Updated Category News Views 4

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Continue Reading
Harbour BioMed Joins Stock Connect, Boosts Investor Access

Updated Category News Views 3

The Big Leap: Harbour BioMed Joins Stock Connect Well, if this ain't something to get excited about—Harbour BioMed just snagged a spot on the Stock Connect roster. This step isn't just ceremonial. We're talking about real access for mainland Chinese investors to dive directly into the shares of Harbour BioMed (HKEX: 02142.HK) through the Shanghai-Hong Kong and...

Continue Reading
MERACH Unveils W60 Plus: A Game Changer for Home Fitness

Updated Category News Views 1

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

Continue Reading
Mermaid Folklore Meets Revolution in New Short Film

Updated Category News Views 2

A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...

Continue Reading
Aroa Biosurgery Reports Low Infection Rates: A Milestone

Updated Category News Views 1

Peer-Reviewed Study: Aroa's Myriad Shows Low Infection Rates Seems like the folks at Aroa Biosurgery have got something solid to brag about in the world of complex soft tissue reconstruction. The company just released interim results from their massive MASTRR Registry study, and the numbers are looking pretty darn promising. We're talking about a 411-patient analysis...

Continue Reading
Softcare Facilitates Standards Delegation Visit to Senegal

Updated Category News Views 3

Ever seen a whole nation's hygiene industry getting a deep dive from not just one, but three major standards bodies? That's what just went down in Senegal. Softcare opened its doors wide to folks from the Senegalese Association for Standardization (ASN), the International Organization for Standardization (ISO), and the Swedish Institute for Standards (SIS). This was no...

Continue Reading

Top 5 Most Recently Viewed Articles

Prinses Máxima Center Enhances Genomics with Callisto™ Innovation

Updated Category News Views 194

Prinses Máxima Center's Partnership with Volta Labs The Prinses Máxima Center for Pediatric Oncology is making headlines with its recent acquisition of the Callisto™ platform from Volta Labs. This major step forward aims to enhance efficiency in sample preparation across a variety of genomics workflows, specifically designed for both Illumina and Oxford Nanopore...

Continue Reading
Boise Hunter Homes Appoints Industry Veteran Julie DeLorenzo

Updated Category News Views 474

Julie DeLorenzo Joins Boise Hunter Homes Boise Hunter Homes welcomes Julie DeLorenzo to its team as the new Director of Community Relations. This strategic move emphasizes the company’s commitment to community building and corporate stewardship. Experience and Community Commitment DeLorenzo comes with extensive experience as an Idaho Realtor, and her dedication to...

Continue Reading
Growth Prospects for Glass Prefilled Syringes in Europe

Updated Category News Views 151

Emerging Trends in the European Market for Glass Prefilled Syringes The market for glass prefilled syringes and vials in Europe is undergoing significant transformations as we witness a rapid development in healthcare and biotechnology sectors. The competitive landscape is shifting, with the adoption of innovative packaging techniques, the rise of biologics as a treatment...

Continue Reading
Man Group PLC Announces Significant Shareholdings Update

Updated Category News Views 112

Clarifying Share Interests of Man Group PLC Understanding the ownership structure in the financial world is crucial for investors. In compliance with the rules set out by the Takeover Code, disclosures regarding significant shareholdings need to be clear and transparent. Recently, Man Group PLC has taken steps to outline its relevant investments, specifically in relation...

Continue Reading
Nutrien Faces Downgrade as UBS Revises Outlook and Price Target

Updated Category News Views 87

UBS Downgrades Nutrien's Rating Amid Agricultural Concerns UBS has recently made headlines by downgrading Nutrien (NYSE: NTR) from a "buy" to a "neutral" rating. This adjustment reflects growing concerns about the agricultural market's performance and the potential impact on the company’s financial health. Weaker Agricultural Market Outlook Analysts at UBS have...

Continue Reading